Product NDC: | 55390-616 |
Proprietary Name: | Ranitidine |
Non Proprietary Name: | Ranitidine hydrochloride |
Active Ingredient(s): | 25 mg/mL & nbsp; Ranitidine hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-616 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074777 |
Marketing Category: | ANDA |
Start Marketing Date: | 20041119 |
Package NDC: | 55390-616-01 |
Package Description: | 1 VIAL in 1 BOX (55390-616-01) > 6 mL in 1 VIAL |
NDC Code | 55390-616-01 |
Proprietary Name | Ranitidine |
Package Description | 1 VIAL in 1 BOX (55390-616-01) > 6 mL in 1 VIAL |
Product NDC | 55390-616 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ranitidine hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20041119 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |